From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management E Mossialos, E Courtin, H Naci, S Benrimoj, M Bouvy, K Farris, P Noyce, ... Health policy 119 (5), 628-639, 2015 | 514 | 2015 |
Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic … B Hill‐Taylor, I Sketris, J Hayden, S Byrne, D O'sullivan, R Christie Journal of clinical pharmacy and therapeutics 38 (5), 360-372, 2013 | 504 | 2013 |
Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney … K Mahalati, P Belitsky, I Sketris, K West, R Panek Transplantation 68 (1), 55-62, 1999 | 494 | 1999 |
Effectiveness of the STOPP/START (Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria … B Hill‐Taylor, KA Walsh, S Stewart, J Hayden, S Byrne, IS Sketris Journal of clinical pharmacy and therapeutics 41 (2), 158-169, 2016 | 280 | 2016 |
Identifying, understanding and overcoming barriers to medication error reporting in hospitals: a focus group study N Hartnell, N MacKinnon, I Sketris, M Fleming BMJ quality & safety 21 (5), 361-368, 2012 | 259 | 2012 |
A comparison of health utility measures for the evaluation of multiple sclerosis treatments JD Fisk, MG Brown, IS Sketris, LM Metz, TJ Murray, KJ Stadnyk Journal of Neurology, Neurosurgery & Psychiatry 76 (1), 58-63, 2005 | 232 | 2005 |
Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study K Mahalati, P Belitsky, K West, B Kiberd, A Fraser, I Sketris, ... Journal of the American Society of Nephrology 12 (4), 828-833, 2001 | 227 | 2001 |
CNODES: the Canadian network for observational drug effect studies S Suissa, D Henry, P Caetano, CR Dormuth, P Ernst, B Hemmelgarn, ... Open Medicine 6 (4), e134, 2012 | 170 | 2012 |
A limited sampling strategy for the measurement of cyclosporine AUC A Johnston, I Sketris, JT Marsden, CG Galustian, T Fashola, D Taube, ... Transplantation proceedings 22 (3), 1345-1346, 1990 | 127 | 1990 |
Optimizing scopes of practice: New models of care for a new health care system S Nelson, J Turnbull, L Bainbridge, T Caulfield, G Hudon, D Kendel, ... Canadian Academy of Health Sciences, 2014 | 123 | 2014 |
Factors affecting compliance with cyclosporine in adult renal transplant patients. I Sketris, N Waite, K Grobler, M West, S Gerus Transplantation proceedings 26 (5), 2538-2541, 1994 | 121 | 1994 |
Independent pharmacist prescribing in Canada MR Law, T Ma, J Fisher, IS Sketris Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 145 (1), 17-23. e1, 2012 | 119 | 2012 |
Strategic opportunities for effective optimal prescribing and medication management IS Sketris, EM Langille Ingram, HL Lummis Can J Clin Pharmacol 16 (1), e103-25, 2009 | 113 | 2009 |
Societal costs of vascular cognitive impairment in older adults K Rockwood, M Brown, H Merry, I Sketris, J Fisk Stroke 33 (6), 1605-1609, 2002 | 113 | 2002 |
Association between incretin-based drugs and the risk of acute pancreatitis L Azoulay, KB Filion, RW Platt, M Dahl, CR Dormuth, KK Clemens, ... JAMA internal medicine 176 (10), 1464-1473, 2016 | 112 | 2016 |
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? MG Brown, S Kirby, C Skedgel, JD Fisk, TJ Murray, V Bhan, IS Sketris Neurology 69 (15), 1498-1507, 2007 | 101 | 2007 |
Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study R Clark, JE Fisher, IS Sketris, GM Johnston BMC clinical pharmacology 12, 1-8, 2012 | 99 | 2012 |
Prescription drug samples–does this marketing strategy counteract policies for quality use of medicines? KEM Groves, I Sketris, SE Tett Journal of clinical pharmacy and therapeutics 28 (4), 259-271, 2003 | 94 | 2003 |
Systematic review: the efficacy of intermittent and on‐demand therapy with histamine H2‐receptor antagonists or proton pump inhibitors for gastro‐oesophageal … J Zacny, M Zamakhshary, I Sketris, S Veldhuyzen van Zanten Alimentary pharmacology & therapeutics 21 (11), 1299-1312, 2005 | 84 | 2005 |
Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary E Reeve, B Farrell, W Thompson, N Herrmann, I Sketris, PJ Magin, ... Medical Journal of Australia 210 (4), 174-179, 2019 | 83 | 2019 |